Displaying 1 - 8 of 8
| Active Ingredient | BENZHEXOL |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (PARKINSONS) |
| Indications | Parkinsonism, especially when tremor and salivation are marked. Drug induced parkinsonism but not tardive dyskinesia. |
| Caution |
Avoid if there is risk of urinary retention. Often abused by chronic psychotics. Dry mouth, G.I. up set, blurred vision, nervousness and confusion. |
| Dose Range |
Adult: 1mg increased to 6-10mg daily in 3-4 divided doses (max. 20mg). |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BENZTROPINE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (PARKINSONS) |
| Indications | Symptomatic treatment of parkinsonism. Alleviation of drug induced extrapy ramidal disorders, but is of no value against tardive dyskinesias. |
| Caution | Urinary retention, blurred vision, nervousness, confusion, drowsiness. |
| Dose Range |
Adult and Children over 12 years: 0.5-1mg daily at bedtime gradually increased to a maximum of 6mg daily . Maintenance dose of 1-4mg daily as a single dose or in divided doses. i.v. or i.m: 1-2mg, repeated until symptoms disappear. Pediatri |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PROCYCLIDINE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (PARKINSONS) |
| Indications | Parkinsonism. |
| Caution | Blurred vision, mydriasis, disorientation, lightheadedness, nausea, vomiting, xerostomia. Safety and effective not established for Pediatric patients. |
| Dose Range | Adult: 2.5mg 3 times a day . M aintenance dose 10-30mg 3-4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IPRATROPIUM BROMIDE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | Chronic obstructive pulmonary disease unresponsive to beta 2 agonists. |
| Caution | Glaucoma, dry mouth, bitter taste. |
| Dose Range |
Adult: 1-2 puffs 3-4 times daily up to 4 puffs. Pediatric: 1-2 puffs 3 times daily . See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OLODATEROL | TIOTROPIUM |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM BROMIDE |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | Maintenance and treatment of reversible airways obstruction seen in chronic obstructive pulmonary disease and asthma. Must be prescribed by a pulmonologist. |
| Caution | Pharyngitis, sinusitis, rhinitis, and epistaxis. |
| Dose Range | Once daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TIOTROPIUM | OLODATEROL |
| Therapeutic Class | ANTICHOLINERGIC AGENTS (RESPIRATORY) |
| Indications | As for Vilanterol/Fluticasone (See p. 365).Prophylaxis of asthma; Long-term maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). |
| Caution | As for Vilanterol/Fluticasone.Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk ofoverdose. Naso-pharyngitis, upper respirator More ... |
| Dose Range | Two puffs once daily, at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |